- Home
- SLS vs TAVI Comparison
SLS vs TAVI Comparison
Compare SLS & TAVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLS
- TAVI
- Stock Information
- Founded
- SLS 2012
- TAVI 2024
- Country
- SLS United States
- TAVI United States
- Employees
- SLS N/A
- TAVI N/A
- Industry
- SLS Biotechnology: Pharmaceutical Preparations
- TAVI
- Sector
- SLS Health Care
- TAVI
- Exchange
- SLS Nasdaq
- TAVI Nasdaq
- Market Cap
- SLS 169.6M
- TAVI 160.8M
- IPO Year
- SLS N/A
- TAVI 2024
- Fundamental
- Price
- SLS $1.71
- TAVI $10.17
- Analyst Decision
- SLS
- TAVI
- Analyst Count
- SLS 0
- TAVI 0
- Target Price
- SLS N/A
- TAVI N/A
- AVG Volume (30 Days)
- SLS 2.9M
- TAVI 5.4K
- Earning Date
- SLS 05-13-2025
- TAVI 01-01-0001
- Dividend Yield
- SLS N/A
- TAVI N/A
- EPS Growth
- SLS N/A
- TAVI N/A
- EPS
- SLS N/A
- TAVI 0.01
- Revenue
- SLS N/A
- TAVI N/A
- Revenue This Year
- SLS N/A
- TAVI N/A
- Revenue Next Year
- SLS N/A
- TAVI N/A
- P/E Ratio
- SLS N/A
- TAVI $2,036.20
- Revenue Growth
- SLS N/A
- TAVI N/A
- 52 Week Low
- SLS $0.77
- TAVI $9.89
- 52 Week High
- SLS $2.12
- TAVI $10.35
- Technical
- Relative Strength Index (RSI)
- SLS 54.26
- TAVI N/A
- Support Level
- SLS $1.36
- TAVI N/A
- Resistance Level
- SLS $2.12
- TAVI N/A
- Average True Range (ATR)
- SLS 0.18
- TAVI 0.00
- MACD
- SLS -0.01
- TAVI 0.00
- Stochastic Oscillator
- SLS 46.05
- TAVI 0.00
About SLS SELLAS Life Sciences Group Inc.
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.
About TAVI Tavia Acquisition Corp. Ordinary Shares
Tavia Acquisition Corp is a blank check company.